115 filings
Page 5 of 6
8-K
qnhvlsf 0nblsti38c
13 May 21
Silverback Therapeutics Reports First Quarter 2021 Financial Results
4:17pm
DEFA14A
tnbyxfp hhlvb
22 Apr 21
Additional proxy soliciting materials
4:02pm
DEF 14A
gzzn4j gm
22 Apr 21
Definitive proxy
4:01pm
S-8
jyobld 69u17zv
29 Mar 21
Registration of securities for employees
4:27pm
10-K
yf9jhgsv55yn
29 Mar 21
Annual report
4:13pm
8-K
mcnvc
29 Mar 21
Silverback Therapeutics Reports Fourth Quarter and Full Year 2020
4:11pm
8-K
otdwi gozm
15 Mar 21
Silverback Therapeutics Announces the Appointment of Dr. Maria Koehler to its Board of Directors
4:05pm
8-K
hm5kfjmnzwapzgm4
8 Dec 20
Silverback Therapeutics Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
5:25pm
S-8
woqurfm
4 Dec 20
Registration of securities for employees
4:15pm
424B4
t5okhan18fnaetp8t2
4 Dec 20
Prospectus supplement with pricing info
4:04pm
EFFECT
7vffxun 6shq5zvs7lzc
4 Dec 20
Notice of effectiveness
12:15am
S-1MEF
ie8pa6fr5wt2
3 Dec 20
Registration of additional securities for an S-1
9:40pm
CERT
u2za vd1txaos6
3 Dec 20
Certification of approval for exchange listing
10:24am
SEC STAFF
0sctk9yptnhhgd9
3 Dec 20
SEC staff action: Order
12:00am
8-A12B
s23fbr1w1 fkj5
1 Dec 20
Registration of securities on exchange
4:31pm
CORRESP
hszp16 sh6
1 Dec 20
Correspondence with SEC
12:00am
CORRESP
gt2aifi6ll5e7e
1 Dec 20
Correspondence with SEC
12:00am
S-1/A
l84 l5xry8
30 Nov 20
IPO registration (amended)
6:06am
CORRESP
9c6t3
30 Nov 20
Correspondence with SEC
12:00am